Antigen-specific reactivity in peripheral blood mononuclear cells from patient no. 6 immunized with HER-2/neu peptide-pulsed dendritic cells
Antigens . | HIV . | GP2 . | E75 . | M1.1 . | M1.2 . | MAGE . | CEA . |
---|---|---|---|---|---|---|---|
Before therapy | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
1. Vaccination | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 |
3. Vaccination | 0.1 | 0.3 | 1.2 | 0.2 | 0.1 | 0.2 | 0.2 |
5. Vaccination | 0.2 | 0.4 | 1.1 | 0.2 | 0.3 | 0.2 | 0.2 |
7. Vaccination | 0.2 | 0.2 | 0.8 | 0.5 | 0.6 | 0.2 | 0.3 |
Antigens . | HIV . | GP2 . | E75 . | M1.1 . | M1.2 . | MAGE . | CEA . |
---|---|---|---|---|---|---|---|
Before therapy | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
1. Vaccination | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 |
3. Vaccination | 0.1 | 0.3 | 1.2 | 0.2 | 0.1 | 0.2 | 0.2 |
5. Vaccination | 0.2 | 0.4 | 1.1 | 0.2 | 0.3 | 0.2 | 0.2 |
7. Vaccination | 0.2 | 0.2 | 0.8 | 0.5 | 0.6 | 0.2 | 0.3 |
Refer to Table 2 for abbreviations.
PBMNCs from each patient were incubated with autologous PBMNCs pulsed with the indicated peptides for 6 hours and IFN-γ production was assessed by flow cytometry after intracellular staining for IFN-γ in CD8 positive lymphocytes. Numbers represent the percentage of IFN-γ–expressing cells in the lymphocyte gate.